menu search

ZBH / Zimmer Biomet Holdings, Inc. (ZBH) CEO Bryan Hanson on Q2 2022 Results - Earnings Call Transcript

Zimmer Biomet Holdings, Inc. (ZBH) CEO Bryan Hanson on Q2 2022 Results - Earnings Call Transcript
Zimmer Biomet Holdings, Inc. (NYSE:ZBH ) Q2 2022 Earnings Conference Call August 2, 2022 8:30 AM ET Company Participants Keri Mattox - Senior Vice President, Chief Communications and Administration Officer Bryan Hanson - Chairman, President, and Chief Executive Officer Suky Upadhyay - Executive Vice President and Chief Financial Officer Ivan Tornos - Chief Operating Officer Conference Call Participants Rick Wise - Stifel Nicolaus Pito Chickering - Deutsche Bank Larry Biegelsen - Wells Fargo Josh Jennings - Cowen & Company Jayson Bedford - Raymond James Kyle Rose - Canaccord Genuity Jason Wittes - Loop Capital Chris Pasquale - Nephron Research Steven Lichtman - Oppenheimer & Company Operator Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Second Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, August 2nd, 2022. Read More
Posted: Aug 2 2022, 13:11
Author Name: Seeking Alpha
Views: 102476

ZBH News  

Zimmer Biomet (ZBH) Reports Next Week: Wall Street Expects Earnings Growth

By Zacks Investment Research
October 31, 2023

Zimmer Biomet (ZBH) Reports Next Week: Wall Street Expects Earnings Growth

Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key e more_horizontal

Will Zimmer Biomet (ZBH) Beat Estimates This Earnings Season?

By Zacks Investment Research
October 30, 2023

Will Zimmer Biomet (ZBH) Beat Estimates This Earnings Season?

Zimmer Biomet (ZBH) is expected to have witnessed strong performance across Avenir Complete hip. more_horizontal

Here's Why You Should Retain Zimmer Biomet (ZBH) for Now

By Zacks Investment Research
September 29, 2023

Here's Why You Should Retain Zimmer Biomet (ZBH) for Now

Investors are optimistic about Zimmer Biomet (ZBH) on business recovery and expansion in emerging markets. more_horizontal

Zimmer Biomet (ZBH) Gains From ROSA Sales Growth Amid FX Woes

By Zacks Investment Research
September 29, 2023

Zimmer Biomet (ZBH) Gains From ROSA Sales Growth Amid FX Woes

Zimmer Biomet (ZBH) plans to work on the overall shift of the company's legacy knee systems to a fully rounded-out Persona portfolio. more_horizontal

Zimmer Biomet Holdings: Growth Strategies For 2023 Instill Confidence

By Seeking Alpha
September 14, 2023

Zimmer Biomet Holdings: Growth Strategies For 2023 Instill Confidence

Zimmer Biomet Holdings outlined strategies to gain market share in the knee sector and foster innovation in hip products. ZBH has raised its 2023 grow more_horizontal

Zimmer Biomet (ZBH) Business Recovery Continues Despite FX Woe

By Zacks Investment Research
September 5, 2023

Zimmer Biomet (ZBH) Business Recovery Continues Despite FX Woe

Zimmer Biomet (ZBH) is benefiting from increased provider capacity, resulting in backlog pull-through in the recent quarters. more_horizontal

Here's Why You Should Retain Zimmer Biomet (ZBH) for Now

By Zacks Investment Research
August 30, 2023

Here's Why You Should Retain Zimmer Biomet (ZBH) for Now

Investors are optimistic about Zimmer Biomet (ZBH) due to innovative new product launches and solid execution. more_horizontal

Zimmer Biomet: Knees The Key Growth Lever, Reiterate Buy On Long-Term Value

By Seeking Alpha
August 12, 2023

Zimmer Biomet: Knees The Key Growth Lever, Reiterate Buy On Long-Term Value

Zimmer Biomet Holdings, Inc. has experienced a selloff alongside the healthcare sector in H2 FY'23. Despite the recent downturn, the company still rep more_horizontal


Search within

Pages Search Results: